Davignon, J <br/><br/>
Methods and endpoint issues in clinical development of lipid-acting agents with pleiotropic effects.  [electronic resource] 

 -  The American journal of cardiology  Apr 1998 
 - 17F-24F p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>0002-9149 
<br/><br/><label>Standard No.: </label>10.1016/s0002-9149(98)00253-7  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Clofibrate--pharmacology<br/>Drug Evaluation--methods<br/>Drug Evaluation, Preclinical<br/>Drugs, Investigational--pharmacology<br/>Humans<br/>Hydroxymethylglutaryl-CoA Reductase Inhibitors--pharmacology<br/>Hyperlipidemias--drug therapy<br/>Hypolipidemic Agents--pharmacology<br/>Legislation, Drug<br/>Probucol--pharmacology